| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0002 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.003 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.004 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.005 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
| mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.007 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.007 |